Mirae Asset Healthcare Fund
Mirae Asset Mutual Fund · FM: Vrijesh Kasera, Tanmay Mehta · INF769K01ED6 · Direct
NAV ₹52.92 AUM ₹3442 Cr as of 21 Sep 2026
Portfolio as of Jul 2026 · Last Update: 16-Aug-2026 05:01 PM IST
Returns
| 1D | 1M | 3M | 6M | 1Y | 3Y | 5Y | Rank (1Y) | TER | |
|---|---|---|---|---|---|---|---|---|---|
| Fund | +0.6% | +2.5% | +9.6% | +25.8% | +19.6% | +24.2% | +16.1% | 1/13 | 0.61% |
Equity allocation
98.74%
Non-equity allocation (combined)
1.26%
All Equity Holdings (27) as of Jul 2026
| # | Company | Value (₹ Cr) | % of AUM | Change |
|---|---|---|---|---|
| 1 | Sun Pharmaceutical Industries Ltd. | 380.6 | 11.06% | — |
| 2 | Divi's Laboratories Ltd. | 299.8 | 8.71% | — |
| 3 | Torrent Pharmaceuticals Ltd. | 257.3 | 7.47% | — |
| 4 | Apollo Hospitals Enterprise Ltd. | 204.5 | 5.94% | — |
| 5 | Glenmark Pharmaceuticals Ltd. | 190.3 | 5.53% | — |
| 6 | Laurus Labs Ltd. | 176.7 | 5.13% | — |
| 7 | Aurobindo Pharma Ltd. | 131.7 | 3.82% | — |
| 8 | Alkem Laboratories Ltd. | 122.5 | 3.56% | — |
| 9 | Fortis Healthcare Ltd. | 122.2 | 3.55% | — |
| 10 | Krishna Institute of Medical Sciences Ltd. | 119.6 | 3.48% | — |
| 11 | Dr. Reddy's Laboratories Ltd. | 119.2 | 3.46% | — |
| 12 | Lupin Ltd. | 112.6 | 3.27% | — |
| 13 | Onesource Specialty Pharma Ltd. | 111.1 | 3.23% | — |
| 14 | Sai Life Sciences Ltd. | 109.1 | 3.17% | — |
| 15 | Aster DM Quality Care Ltd. | 108.1 | 3.14% | — |
| 16 | IPCA Laboratories Ltd. | 107.9 | 3.13% | — |
| 17 | Cipla Ltd. | 104.4 | 3.03% | — |
| 18 | Eris Lifesciences Ltd. | 97.2 | 2.82% | — |
| 19 | Dr. Lal Path labs Ltd. | 96.9 | 2.81% | — |
| 20 | Max Healthcare Institute Ltd. | 96.8 | 2.81% | — |
| 21 | Gland Pharma Ltd. | 72.6 | 2.11% | — |
| 22 | Biocon Ltd. | 71.5 | 2.08% | — |
| 23 | Mankind Pharma Ltd. | 70.2 | 2.04% | — |
| 24 | Narayana Hrudayalaya Ltd. | 40.9 | 1.19% | — |
| 25 | Anthem Biosciences Ltd. | 39.5 | 1.15% | — |
| 26 | Neogen Chemicals Ltd. | 20.8 | 0.61% | — |
| 27 | Deepak Nitrite Ltd. | 15.2 | 0.44% | — |
All disclosed equity positions are shown. Non-equity allocation is the remaining portfolio weight after disclosed equities.